Document is current
Any future updates will be listed below
-
Authors
Huang, Wenzhong
Xu, Rongbin
Wu, Yao
Yang, Zhengyu
Ye, Zhoufeng
Wong, Ee Ming
Southey, Melissa C.
Hopper, John L.
Abramson, Michael J.
Li, Shanshan
Li, Shuai
Guo, Yuming
-
Funding
Funding for this research was provided by:
China Scholarship Council (202006380055)
China Scholarship Council (202006010044)
VicHealth Postdoctoral Research Fellowships
Monash Graduate Scholarship
Victorian Cancer Agency
Cancer Australia and National Breast Cancer Foundation
Australian National Health and Medical Research Council
- License Information
-
More Information
Article History
Received: 19 December 2025
Accepted: 9 April 2026
First Online: 20 April 2026
Declarations
:
: Written informed consent was obtained from all participants prior to enrollment. Ethical approval was received from the Monash University Human Research Ethics Committee (reference number: 17813).
: This manuscript does not contain any individual person’s data in any form (including individual details, images, or videos). Therefore, consent for publication was not required.
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: MJA held investigator-initiated grants from Pfizer, Boehringer-Ingelheim, GlaxoSmithKline and Sanofi for unrelated research. He has undertaken an unrelated consultancy for Sanofi. He also received a speaker’s fee from GSK. The other authors declare no competing interests.
